1中慧元通-B通过聆讯，将于本周内开启招股港交所7月27日披露，江苏中慧元通生物科技股份有限公司（以下简称“中慧元通”）已通过港交所主板聆讯，中金公司、摩根士丹利、瑞银集团为联席保荐人。中慧元通已于6月26日获中国证监会境外发行上市及境内未上市股份“全流通”备案，最早将于本周内开启招股。中慧元通成立于2015年，致力于创新疫苗及采用新技术方法的传统疫苗的研发、制造及商业化。公司目前拥有四价流感病毒...
Source Link1中慧元通-B通过聆讯，将于本周内开启招股港交所7月27日披露，江苏中慧元通生物科技股份有限公司（以下简称“中慧元通”）已通过港交所主板聆讯，中金公司、摩根士丹利、瑞银集团为联席保荐人。中慧元通已于6月26日获中国证监会境外发行上市及境内未上市股份“全流通”备案，最早将于本周内开启招股。中慧元通成立于2015年，致力于创新疫苗及采用新技术方法的传统疫苗的研发、制造及商业化。公司目前拥有四价流感病毒...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.